It affects, among other things, menstrual disorders and fertility problemsand
The global microfluidics in oncology market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2025 to 2034.
Gamma-glutamyltransferase 1 promotes clear cell renal cell carcinoma initiation and progression
The adipose tissue as an endocrine organ
Poor diet, chronic stress, UV exposure, and environmental pollution are all contributors to such a condition
Quality Check was performed according to the established pipeline used by previous epidemiological studies and international metabolomics consortia [31, 43,44,45]